Patrick Doonan | Director of Antibody Engineering
Ailux

Patrick Doonan, Ph.D. is a Director of Alliance Management and Antibody Engineering at Ailux. He brings over a decade of industry experience in the field of antibody drug discovery from target ID to FIH. During his tenure at Pfizer and Janssen, he published several high impact journals, furthering efforts in bispecifics, ADCs, and costimulation across multiple disease areas. His postdoctoral work at the University of Pennsylvania focused on calcium regulation of CART while collaborating with the Carl June lab. His recent focus has been to bring AI-driven drug discovery into use across different modalities.